GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boule Diagnostics AB (OSTO:BOUL) » Definitions » Debt-to-Equity

Boule Diagnostics AB (OSTO:BOUL) Debt-to-Equity : 0.36 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Boule Diagnostics AB Debt-to-Equity?

Boule Diagnostics AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr105.0 Mil. Boule Diagnostics AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was kr73.4 Mil. Boule Diagnostics AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr498.0 Mil. Boule Diagnostics AB's debt to equity for the quarter that ended in Mar. 2024 was 0.36.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Boule Diagnostics AB's Debt-to-Equity or its related term are showing as below:

OSTO:BOUL' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.09   Med: 0.38   Max: 0.73
Current: 0.36

During the past 13 years, the highest Debt-to-Equity Ratio of Boule Diagnostics AB was 0.73. The lowest was 0.09. And the median was 0.38.

OSTO:BOUL's Debt-to-Equity is ranked worse than
61.71% of 700 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs OSTO:BOUL: 0.36

Boule Diagnostics AB Debt-to-Equity Historical Data

The historical data trend for Boule Diagnostics AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boule Diagnostics AB Debt-to-Equity Chart

Boule Diagnostics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.47 0.53 0.41 0.35

Boule Diagnostics AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.38 0.39 0.35 0.36

Competitive Comparison of Boule Diagnostics AB's Debt-to-Equity

For the Medical Devices subindustry, Boule Diagnostics AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boule Diagnostics AB's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Boule Diagnostics AB's Debt-to-Equity falls into.



Boule Diagnostics AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Boule Diagnostics AB's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Boule Diagnostics AB's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boule Diagnostics AB  (OSTO:BOUL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Boule Diagnostics AB Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Boule Diagnostics AB's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Boule Diagnostics AB (OSTO:BOUL) Business Description

Traded in Other Exchanges
N/A
Address
Domnarvsgatan 4, Spanga, SWE, SE-163 53
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.

Boule Diagnostics AB (OSTO:BOUL) Headlines

No Headlines